Cargando…
Myeloperoxidase to Risk Stratify Emergency Department Patients with Chest Pain
Previous studies suggest that serum myeloperoxidase (MPO) is a potentially useful biomarker to risk stratify troponin-negative patients with suspected myocardial ischemia. We hypothesized that the relationship between initial serum MPO levels would correlate with 30-day adverse cardiac outcomes for...
Autores principales: | Manini, Alex F., McAfee, Andrew T., Noble, Vicki E., Bohan, J. Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614767/ https://www.ncbi.nlm.nih.gov/pubmed/23675127 |
Ejemplares similares
-
Using HEART2 score to risk stratify chest pain patients in the Emergency Department: an observational study
por: Schrader, Chet D., et al.
Publicado: (2022) -
Effective combination of isolated symptom variables to help stratifying acute undifferentiated chest pain in the emergency department
por: Zheng, Wen, et al.
Publicado: (2019) -
Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department
por: Backus, B.E, et al.
Publicado: (2011) -
Improving Risk Stratification of Patients With Chest Pain in the Emergency Department
por: Altunoz, Yusuf, et al.
Publicado: (2023) -
Enterprise 2.0: how to manage social technologies to transform your organization
por: McAfee, Andrew
Publicado: (2009)